Literature DB >> 19855426

Angiogenic factor abnormalities and fetal demise in a twin pregnancy.

Michelle A Hladunewich1, Guy Steinberg, S Ananth Karumanchi, Richard J Levine, Sarah Keating, John Kingdom, Johannes Keunen.   

Abstract

BACKGROUND: An otherwise healthy 31-year-old gravida 2 para 1 woman with a spontaneous dichorionic, diamniotic twin pregnancy presented with hypertension, nephrotic syndrome and renal insufficiency at 19 weeks' gestation. Fetal ultrasound revealed severe intrauterine growth restriction of one fetus and measurement of serum anti-angiogenic and angiogenic factors were consistent with a profound anti-angiogenic state. After one fetus died and the placenta became increasingly echogenic, the patient improved clinically, and weekly ultrasound assessments of the intact co-twin from 22 weeks onwards demonstrated symmetrical fetal growth along the 10th centile. Repeat serum angiogenic factors at 24 weeks' gestation revealed considerable improvement of the anti-angiogenic state and paralleled resolution of the clinical syndrome. INVESTIGATIONS: Physical examination, laboratory evaluations including full blood count, liver function tests, electrolytes, renal function tests, screening for glomerular-based disease, 24-h urine collection for total protein, analysis of serum anti-angiogenic and angiogenic factors, fetal ultrasonography and placental Doppler examination. DIAGNOSIS: Spontaneous resolution of early-onset pre-eclampsia after single fetal demise in a twin pregnancy. MANAGEMENT: Labetalol was given to treat hypertension and furosemide was given as needed for edema. The patient was closely followed up throughout pregnancy in a combined nephrology/obstetrics outpatient clinic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855426     DOI: 10.1038/nrneph.2009.154

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  19 in total

1.  A role of the anti-angiogenic factor sVEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome).

Authors:  Jimmy Espinoza; Roberto Romero; Jyh Kae Nien; Juan Pedro Kusanovic; Karina Richani; Ricardo Gomez; Chong Jai Kim; Pooja Mittal; Francesca Gotsh; Offer Erez; Tinnakorn Chaiworapongsa; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2006-10

2.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

3.  Temporary resolution of preeclamptic symptoms after intrauterine death of one twin.

Authors:  Frank Bschierl; Ernst Beinder
Journal:  Hypertens Pregnancy       Date:  2005       Impact factor: 2.108

4.  Resolution of pre-eclampsia following intrauterine death of one twin.

Authors:  P Sarhanis; D H Pugh
Journal:  Br J Obstet Gynaecol       Date:  1992-02

5.  Selective fetocide reverses preeclampsia in discordant twins.

Authors:  Francois Audibert; Laurent J Saloman; René Frydman
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

6.  Renal biopsy during pregnancy: 'to b . . . or not to b . . .?'.

Authors:  M D Lindheimer; J M Davison
Journal:  Br J Obstet Gynaecol       Date:  1987-10

Review 7.  Partial hydatidiform molar pregnancy presenting with severe preeclampsia prior to twenty weeks gestation: a case report and review of the literature.

Authors:  P C Brittain; P Bayliss
Journal:  Mil Med       Date:  1995-01       Impact factor: 1.437

8.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

9.  Selective fetocide reverses preeclampsia in discordant twins.

Authors:  Kent D Heyborne; Richard P Porreco
Journal:  Am J Obstet Gynecol       Date:  2004-08       Impact factor: 8.661

10.  Nature of glomerular dysfunction in pre-eclampsia.

Authors:  R A Lafayette; M Druzin; R Sibley; G Derby; T Malik; P Huie; C Polhemus; W M Deen; B D Myers
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

View more
  5 in total

1.  An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Adi L Tarca; Maria Teresa Gervasi; Juan Pedro Kusanovic; Pooja Mittal; Giovanna Ogge; Edi Vaisbuch; Shali Mazaki-Tovi; Zhong Dong; Sun Kwon Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-12

Review 2.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

Review 3.  The etiology of preeclampsia.

Authors:  Eunjung Jung; Roberto Romero; Lami Yeo; Nardhy Gomez-Lopez; Piya Chaemsaithong; Adithep Jaovisidha; Francesca Gotsch; Offer Erez
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

Review 4.  Angiogenic factors and preeclampsia.

Authors:  Sharon E Maynard; S Ananth Karumanchi
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

Review 5.  A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.

Authors:  Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2016-03-17       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.